Stockscreener 앱 받기
0.8404
3.26%
-0.0283
시간 외 거래:
.85
0.0096
+1.14%
전일 마감가:
$0.8687
열려 있는:
$0.8906
하루 거래량:
46,682
Relative Volume:
0.14
시가총액:
$4.38M
수익:
-
순이익/손실:
$-18.68M
주가수익비율:
-0.1136
EPS:
-7.3948
순현금흐름:
$-15.70M
1주 성능:
-11.32%
1개월 성능:
-18.41%
6개월 성능:
-87.78%
1년 성능:
-93.05%
1일 변동 폭
$0.836
$0.8906
1주일 범위
$0.836
$0.9782
52주 변동 폭
$0.731
$14.68
Fibrobiologics Inc Stock (FBLG) Company Profile
명칭
Fibrobiologics Inc
전화
281-671-5150
주소
455 E. MEDICAL CENTER BLVD, HOUSTON
Compare FBLG vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.8404 | 4.52M | 0 | -18.68M | -15.70M | -7.3948 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-12 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-30 | 개시 | H.C. Wainwright | Buy |
| 2024-09-24 | 개시 | Maxim Group | Buy |
Fibrobiologics Inc 주식(FBLG)의 최신 뉴스
FibroBiologics (FBLG) Completes Key Drug Batch for Clinical Tria - GuruFocus
FibroBiologics completes third batch of diabetic foot ulcer drug - Investing.com
FibroBiologics says one more batch should finish its diabetes foot ulcer trial - Stock Titan
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - BioSpace
FibroBiologics CEO, chief scientist join cell therapy conference chat - Stock Titan
FibroBiologics Secures Up to $9 Million in At-the-Market Private Placement to Advance Cell Therapy Pipeline 1 - Minichart
FibroBiologics closes $3M private placement with warrants - Investing.com UK
FibroBiologics closes $3M private placement with warrants By Investing.com - Investing.com South Africa
FibroBiologics Raises $3.0 Million in Private Placement; Issues Pre-Funded and Common Warrants - TradingView
FibroBiologics (FBLG) closes $3M placement with $6M warrant upside - Stock Titan
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - STLtoday.com
FibroBiologics, Inc. announced that it has received $3 million in funding - marketscreener.com
Press Release: FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - 富途牛牛
Enterprise value to revenue forward of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Price to book forward of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Price to earnings forward of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Enterprise value to EBIT forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
Enterprise value to revenue forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
Number of shareholders of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Enterprise value to EBITDA forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
Price to sales forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
FibroBiologics, Inc. Actuals & Estimates (NASDAQ:FBLG) - TradingView
FibroBiologics raises $3M in private placement offering By Investing.com - Investing.com Australia
FibroBiologics (FBLG) Prices $9M Private Placement with Warrants - GuruFocus
FibroBiologics, Inc. Actuals & Estimates (LS:A426UV) - TradingView
FibroBiologics (FBLG) Secures $3M Through Private Placement Offe - GuruFocus
FibroBiologics raises $3M in private placement offering - Investing.com
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - STLtoday.com
FBLG Forecast — Price Target — Prediction for 2027 - TradingView
SG00 Forecast — Price Target — Prediction for 2027 - TradingView
A426UV Forecast — Price Target — Prediction for 2027 - TradingView
FibroBiologics, Inc. announced that it expects to receive $3 million in funding - marketscreener.com
Form 8K Fibrobiologics Inc For: 23 June By Investing.com - Investing.com India
FibroBiologics, Inc. Adopts 2026 Equity and Incentive Compensation Plan – Key Terms, Stock Option Agreement & SEC Filing Overview – Minichart - Minichart
Form 4 Fibrobiologics Inc For: 23 June By Investing.com - Investing.com Nigeria
Form 8K Fibrobiologics Inc For: 23 June - Investing.com UK
Director at FibroBiologics (FBLG) receives stock options for 30,803 shares - Stock Titan
FibroBiologics (FBLG) director receives grant of 30,803 stock options at $0.7503 - Stock Titan
30,803 options granted to FibroBiologics (FBLG) director Olivia - Stock Titan
FibroBiologics stockholders approve new equity and incentive compensation plan By Investing.com - Investing.com Nigeria
FibroBiologics stockholders approve new equity and incentive compensation plan - Investing.com
[8-K] FibroBiologics, Inc. Reports Material Event - Stock Titan
Fibrobiologics, Inc. Announces Non Standing for Re-Election of Stacy Coen to the Board - marketscreener.com
FibroBiologics (FBLG) AGM 2026 Summary - Quartr
FibroBiologics | 4: Statement of changes in beneficial ownership of securities-Director Niklas Victoria Ninon Olivia - Moomoo
FBLG: All proposals passed, board changes noted, and Nasdaq compliance risks discussed - TradingView
FibroBiologics receives patent allowance for wound therapy - Investing.com UK
Fibrobiologics Inc (FBLG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
2.48%
자본화:
|
볼륨(24시간):